Citation 85283

PISTELLI,L: BERTOLI,A: MORELLI,I: SCARPATO,R:. (1998). CONSTITUENTS OF BUPLEURUM SPP. FROM ITALIAN FLORA: ISOLATION, STRUCTURE ELUCIDATION AND THEIR BIOLOGICAL ACTIVITY.. 2(2)

Citation Details

Title	CONSTITUENTS OF BUPLEURUM SPP. FROM ITALIAN FLORA: ISOLATION, STRUCTURE ELUCIDATION AND THEIR BIOLOGICAL ACTIVITY.
Authors	PISTELLI,L: BERTOLI,A: MORELLI,I: SCARPATO,R:
Year	1998
Volume	2
Issue	2

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (4)

Bupleurum fruticosum (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEAN-11-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-DIHYDROXY-13-28-EPOXY:	None
2	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-11-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-DIHYDROXY-13-28-EPOXY:	INACTIVE
3	GENOTOXICITY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-11-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-DIHYDROXY-13-28-EPOXY:OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-28-TRIHYDROXY-11-ALPHA-METHOXY:OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,11-ALPHA-16-BETA-23-28-TETRAHYDROXY:	INACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-11-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-DIHYDROXY-13-28-EPOXY:	INACTIVE
5	ANTIMITOTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-11-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-DIHYDROXY-13-28-EPOXY:	INACTIVE
6	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-28-TRIHYDROXY-11-ALPHA-METHOXY:	None
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-28-TRIHYDROXY-11-ALPHA-METHOXY:	WEAK ACTIVITY
8	ANTIMITOTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-28-TRIHYDROXY-11-ALPHA-METHOXY:	INACTIVE
9	ANTIMITOTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-28-TRIHYDROXY-11-ALPHA-METHOXY:	ACTIVE
10	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-28-TRIHYDROXY-11-ALPHA-METHOXY:	ACTIVE
11	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,16-BETA-23-28-TRIHYDROXY-11-ALPHA-METHOXY:	WEAK ACTIVITY
12	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,11-ALPHA-16-BETA-23-28-TETRAHYDROXY:	None
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,11-ALPHA-16-BETA-23-28-TETRAHYDROXY:	WEAK ACTIVITY
14	ANTIMITOTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-12-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,11-ALPHA-16-BETA-23-28-TETRAHYDROXY:	INACTIVE
15	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEAN-11-EN-3-BETA-OL-[BETA-D-GLUCOPYRANOSYL(1-2)]-[BETA-D-GLUCOPYRANOSYL(1-3)]-BETA-D-FUCOPYRANOSIDE,23-ACETOXY-16-BETA-HYDROXY-13-28-EPOXY:	None
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CAPENSIN	None
17	Not specified	ISOLATION AND IDENTIFICATION OF	PRENYLETINSCOPOLETINSCOPARONE	None
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	COUMARIN,7-(2-HYDROXY-3-METHYL-3-BUTENYL-OXY)-6-METHOXY:	None
19	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AESCULETIN	None
20	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FRAXETIN	None
21	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	COUMARIN,5-7-DIHYDROXY-6-METHOXY-8-(3'-METHYL-2'-BUTENYL):	None

Bupleurum fruticosum (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	PROP-2-EN-1-OL-CIS-2-[CIS-2-METHYL-2-BUTENYL-OXY-METHYL]-BUTENOATE,TRANS-3-(3-4-DIMETHOXY-PHENYL):	None
2	GENOTOXICITY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROP-2-EN-1-OL-CIS-2-[CIS-2-METHYL-2-BUTENYL-OXY-METHYL]-BUTENOATE,TRANS-3-(3-4-DIMETHOXY-PHENYL):	INACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROP-2-EN-1-OL-CIS-2-[CIS-2-METHYL-2-BUTENYL-OXY-METHYL]-BUTENOATE,TRANS-3-(3-4-DIMETHOXY-PHENYL):	WEAK ACTIVITY
4	ANTIMITOTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROP-2-EN-1-OL-CIS-2-[CIS-2-METHYL-2-BUTENYL-OXY-METHYL]-BUTENOATE,TRANS-3-(3-4-DIMETHOXY-PHENYL):	INACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	PROP-2-EN-1-OL-CIS-2-[CIS-2-METHYL-2-BUTENYL-OXY-METHYL]-BUTENOATE,TRANS-3-(4-METHOXY-PHENYL):	None
6	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BENZENE,1-2-DIMETHOXY-4-(1-METHOXY-2-PROPENYL):	None
7	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BENZENE,1-2-DIMETHOXY-4-(3-METHOXY-1-PROPENYL):	None
8	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PRENYLETINCINNAMALDEHYDE,3-4-DIMETHOXY:	None

Bupleurum fruticosum (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	OLEAN-11-13(18)-DIEN-3-BETA-OL-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-FUCOPYRANOSIDE,16-ALPHA-23-28-30-TETRAHYDROXY:	None
2	GENOTOXICITY ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-11-13(18)-DIEN-3-BETA-OL-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-FUCOPYRANOSIDE,16-ALPHA-23-28-30-TETRAHYDROXY:	INACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-11-13(18)-DIEN-3-BETA-OL-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-FUCOPYRANOSIDE,16-ALPHA-23-28-30-TETRAHYDROXY:	WEAK ACTIVITY
4	ANTIMITOTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEAN-11-13(18)-DIEN-3-BETA-OL-BETA-D-GLUCOPYRANOSYL(1-3)-BETA-D-FUCOPYRANOSIDE,16-ALPHA-23-28-30-TETRAHYDROXY:	INACTIVE

Bupleurum falcatum (APIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	GUAIJAVERIN	None
2	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AVICULARIN	None
3	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	RUTIN	None

Citation 85283

Citation Details

Summary

Organisms and Their Experiments (4)

Bupleurum fruticosum (APIACEAE)

Bupleurum fruticosum (APIACEAE)

Bupleurum fruticosum (APIACEAE)

Bupleurum falcatum (APIACEAE)

Show SPARQL Queries (1)

Query 1